Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Losartan potassium api?

See the DrugPatentWatch profile for Losartan

Losartan potassium API refers to the active pharmaceutical ingredient (API) in the drug Losartan potassium [1]. Losartan potassium is used to treat high blood pressure and to help protect the kidneys in people with type 2 diabetes [1]. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs) [1].

What is Losartan Potassium Used For?


Losartan potassium is prescribed to manage hypertension (high blood pressure) [1]. By blocking the action of angiotensin II, a substance in the body that narrows blood vessels, Losartan potassium helps to relax blood vessels, thereby lowering blood pressure [1]. It is also indicated for nephropathy (kidney disease) in patients with type 2 diabetes and hypertension [1].

How Does Losartan Potassium Work?


Losartan potassium functions by inhibiting the binding of angiotensin II to its receptor (AT1) found in smooth muscle and adrenal gland tissue [1]. This blockage prevents the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to a reduction in blood pressure [1].

When Does Losartan Potassium Patent Expiration Occur?


Information regarding the specific patent expiration dates for Losartan potassium can be found through resources that track pharmaceutical patents. DrugPatentWatch.com is a resource that provides such details [2].

Who Makes Losartan Potassium API?


Numerous pharmaceutical manufacturers produce Losartan potassium API. Companies that specialize in API synthesis are involved in its production. Specific manufacturers can often be identified through industry directories and regulatory filings.

What Are the Potential Side Effects of Losartan Potassium?


Common side effects of Losartan potassium can include dizziness, fatigue, headache, and upper respiratory tract infection [1]. Less common but more serious side effects may occur, and patients should consult with a healthcare professional for a comprehensive list and to report any concerns [1].

Are There Alternatives to Losartan Potassium?


Yes, there are alternative medications for treating high blood pressure and related conditions. These include other ARBs, as well as different classes of antihypertensive drugs such as ACE inhibitors, calcium channel blockers, diuretics, and beta-blockers [1]. The choice of medication depends on individual patient factors and medical history.

How is Losartan Potassium Regulated?


Like all APIs and finished drug products, Losartan potassium is subject to stringent regulatory oversight by health authorities such as the U.S. Food and Drug Administration (FDA) [3]. This regulation ensures the quality, safety, and efficacy of the drug through manufacturing standards and approval processes.

What Clinical Data Supports Losartan Potassium Efficacy?


Clinical trials have demonstrated the efficacy of Losartan potassium in reducing blood pressure and slowing the progression of kidney disease in patients with type 2 diabetes and hypertension [1]. These studies form the basis for its approval and prescription.

What Are the Risks Associated with Losartan Potassium API Production?


The production of any API, including Losartan potassium, carries inherent risks related to chemical synthesis, quality control, and environmental impact. Manufacturers must adhere to Good Manufacturing Practices (GMP) to mitigate these risks and ensure product purity and safety [3].

Sources:

[1] National Institutes of Health. "Losartan." MedlinePlus.
[2] DrugPatentWatch.com.
[3] U.S. Food and Drug Administration.



Other Questions About Losartan :

What are the current market trends for losartan? How long is losartan good for? Losartan volume in kilograms? Losartan cause weight gain? Losartan interactions with grapefruit? Losartan and weight gain? How has losartan's demand changed in the past year?